These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 27053444)

  • 1. Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial.
    Kelbæk H; Høfsten DE; Køber L; Helqvist S; Kløvgaard L; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; De Backer O; Bang LE; Kofoed KF; Lønborg J; Ahtarovski K; Vejlstrup N; Bøtker HE; Terkelsen CJ; Christiansen EH; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Jensen LO; Clemmensen P; Grande P; Madsen JK; Torp-Pedersen C; Engstrøm T
    Lancet; 2016 May; 387(10034):2199-206. PubMed ID: 27053444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
    Engstrøm T; Kelbæk H; Helqvist S; Høfsten DE; Kløvgaard L; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L;
    Lancet; 2015 Aug; 386(9994):665-71. PubMed ID: 26347918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial Damage in Patients With Deferred Stenting After STEMI: A DANAMI-3-DEFER Substudy.
    Lønborg J; Engstrøm T; Ahtarovski KA; Nepper-Christensen L; Helqvist S; Vejlstrup N; Kyhl K; Schoos MM; Ghotbi A; Göransson C; Bertelsen L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Kløvgaard L; Høfsten DE; Køber L; Kelbæk H;
    J Am Coll Cardiol; 2017 Jun; 69(23):2794-2804. PubMed ID: 28595694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial.
    Sabate M; Cequier A; Iñiguez A; Serra A; Hernandez-Antolin R; Mainar V; Valgimigli M; Tespili M; den Heijer P; Bethencourt A; Vazquez N; Gómez-Hospital JA; Baz JA; Martin-Yuste V; van Geuns RJ; Alfonso F; Bordes P; Tebaldi M; Masotti M; Silvestro A; Backx B; Brugaletta S; van Es GA; Serruys PW
    Lancet; 2012 Oct; 380(9852):1482-90. PubMed ID: 22951305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial.
    von Birgelen C; Sen H; Lam MK; Danse PW; Jessurun GA; Hautvast RW; van Houwelingen GK; Schramm AR; Gin RM; Louwerenburg JW; de Man FH; Stoel MG; Löwik MM; Linssen GC; Saïd SA; Nienhuis MB; Verhorst PM; Basalus MW; Doggen CJ; Tandjung K
    Lancet; 2014 Feb; 383(9915):413-23. PubMed ID: 24183564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
    Holmvang L; Kelbæk H; Kaltoft A; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
    JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI).
    Carrick D; Oldroyd KG; McEntegart M; Haig C; Petrie MC; Eteiba H; Hood S; Owens C; Watkins S; Layland J; Lindsay M; Peat E; Rae A; Behan M; Sood A; Hillis WS; Mordi I; Mahrous A; Ahmed N; Wilson R; Lasalle L; Généreux P; Ford I; Berry C
    J Am Coll Cardiol; 2014 May; 63(20):2088-2098. PubMed ID: 24583294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial.
    Sabaté M; Brugaletta S; Cequier A; Iñiguez A; Serra A; Hernádez-Antolín R; Mainar V; Valgimigli M; Tespili M; den Heijer P; Bethencourt A; Vázquez N; Backx B; Serruys PW
    JACC Cardiovasc Interv; 2014 Jan; 7(1):64-71. PubMed ID: 24332423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial.
    Jolly SS; Cairns JA; Yusuf S; Rokoss MJ; Gao P; Meeks B; Kedev S; Stankovic G; Moreno R; Gershlick A; Chowdhary S; Lavi S; Niemela K; Bernat I; Cantor WJ; Cheema AN; Steg PG; Welsh RC; Sheth T; Bertrand OF; Avezum A; Bhindi R; Natarajan MK; Horak D; Leung RC; Kassam S; Rao SV; El-Omar M; Mehta SR; Velianou JL; Pancholy S; Džavík V;
    Lancet; 2016 Jan; 387(10014):127-35. PubMed ID: 26474811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
    Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ
    JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial.
    Valgimigli M; Campo G; Percoco G; Bolognese L; Vassanelli C; Colangelo S; de Cesare N; Rodriguez AE; Ferrario M; Moreno R; Piva T; Sheiban I; Pasquetto G; Prati F; Nazzaro MS; Parrinello G; Ferrari R;
    JAMA; 2008 Apr; 299(15):1788-99. PubMed ID: 18375998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial.
    Hahn JY; Song YB; Oh JH; Cho DK; Lee JB; Doh JH; Kim SH; Jeong JO; Bae JH; Kim BO; Cho JH; Suh IW; Kim DI; Park HK; Park JS; Choi WG; Lee WS; Kim J; Choi KH; Park TK; Lee JM; Yang JH; Choi JH; Choi SH; Gwon HC;
    Lancet; 2018 Mar; 391(10127):1274-1284. PubMed ID: 29544699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study.
    Kelbæk H; Engstrøm T; Ahtarovski KA; Lønborg J; Vejlstrup N; Pedersen F; Holmvang L; Helqvist S; Saunamäki K; Jørgensen E; Clemmensen P; Kløvgaard L; Tilsted HH; Raungaard B; Ravkilde J; Aaroe J; Eggert S; Køber L
    EuroIntervention; 2013 Feb; 8(10):1126-33. PubMed ID: 23425538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea.
    Hong SJ; Lee SJ; Lee SH; Lee JY; Cho DK; Kim JW; Kim SM; Hur SH; Heo JH; Jang JY; Koh JS; Won H; Lee JW; Hong SJ; Kim DK; Choe JC; Lee JB; Kim SJ; Yang TH; Lee JH; Hong YJ; Ahn JH; Lee YJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y; Kim BK;
    Lancet; 2024 Sep; 404(10457):1029-1039. PubMed ID: 39236729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial.
    Diletti R; den Dekker WK; Bennett J; Schotborgh CE; van der Schaaf R; Sabaté M; Moreno R; Ameloot K; van Bommel R; Forlani D; van Reet B; Esposito G; Dirksen MT; Ruifrok WPT; Everaert BRC; Van Mieghem C; Elscot JJ; Cummins P; Lenzen M; Brugaletta S; Boersma E; Van Mieghem NM;
    Lancet; 2023 Apr; 401(10383):1172-1182. PubMed ID: 36889333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: Ischemic postconditioning or deferred stent implantation versus conventional primary angioplasty and complete revascularization versus treatment of culprit lesion only: Rationale and design of the DANAMI 3 trial program.
    Høfsten DE; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Clemmensen P; Torp-Pedersen C; Tilsted HH; Bøtker HE; Jensen LO; Køber L; Engstrøm T;
    Am Heart J; 2015 May; 169(5):613-21. PubMed ID: 25965708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.
    Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G
    JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial.
    Collet JP; Silvain J; Barthélémy O; Rangé G; Cayla G; Van Belle E; Cuisset T; Elhadad S; Schiele F; Lhoest N; Ohlmann P; Carrié D; Rousseau H; Aubry P; Monségu J; Sabouret P; O'Connor SA; Abtan J; Kerneis M; Saint-Etienne C; Beygui F; Vicaut E; Montalescot G;
    Lancet; 2014 Nov; 384(9954):1577-85. PubMed ID: 25037988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial.
    Li Y; Liang Z; Qin L; Wang M; Wang X; Zhang H; Liu Y; Li Y; Jia Z; Liu L; Zhang H; Luo J; Dong S; Guo J; Zhu H; Li S; Zheng H; Liu L; Wu Y; Zhong Y; Qiu M; Han Y; Stone GW
    Lancet; 2022 Nov; 400(10366):1847-1857. PubMed ID: 36351459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased rate of stent thrombosis and target lesion revascularization after filter protection in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: 15-month follow-up of the DEDICATION (Drug Elution and Distal Protection in ST Elevation Myocardial Infarction) trial.
    Kaltoft A; Kelbaek H; Kløvgaard L; Terkelsen CJ; Clemmensen P; Helqvist S; Lassen JF; Thuesen L
    J Am Coll Cardiol; 2010 Mar; 55(9):867-71. PubMed ID: 20185036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.